Diabetes mellitus exacerbates advanced glycation end product accumulation in the veins of end-stage renal failure patients

Abstract

The excess accumulation of advanced glycation end products (AGEs) contributes to the chronic complications of type 2 diabetes mellitus (DM) and renal failure. Biopsy specimens (n = 184) of arterial (n = 92) and venous (n = 92) tissues were obtained (radial artery and cephalic vein) from end-stage renal disease (ESRD) patients with or without DM and normal healthy subjects (n = 12) requiring surgery (trauma patients). Immunohistochemical assessment of the blood vessels revealed the presence of pentosidine (AGE marker) in both veins and arteries in 72% of the ESRD patients. The percentage of arteries and veins that showed positive pentosidine staining in ESRD patients with type 2 DM alone was 100% and 92% respectively, in the non-diabetic ESRD patients it was <70% (for arteries and veins), and in the ESRD patients with hypertension as an additional co-morbidity to type 2 DM it was 70% and 82%, respectively. The veins of ESRD patients with DM showed a strong (+++) positive staining and very strong (++++) positive staining was observed in the patients with DM and hypertension. Only mild (+) or moderate (++) pentosidine staining intensity was observed in the arteries of ESRD patients without or with comorbidities, respectively. The accumulation of AGE in the vein rather than the artery may be a better reflection of the extent of complications of ESRD.

Keywords

AGE artery diabetes mellitus ESRD pentosidine vein

References

Miyata T , Maeda K , Kurokawa K , van Ypersele de Strihou C . Oxidation conspires with glycation to generate noxious advanced glycation end products in renal failure. Nephrol Dial Transplant 1997; 12: 255–258.

Kaysen GA . The microinflammatory state in uremia: causes and potential consequences. J Am Soc Nephrol 2001; 12: 1549–1557.

Takaeuchi M , Yanase Y , Matsuura N et al. Immunological detection of a novel advanced glycation end-product. Mol Med 2001; 11: 783–791.

Floridi A , Antolini F , Galli F , Fagugli RM , Floridi E , Buocristiani U . Daily hemodialysis improves indices of protein glycation. Nephrol Dial Transplant 2002; 17: 871–878.

Izuhara Y , Miyata T , Ueda Y et al. A sensitive and specific ELISA for plasma pentosidine. Nephrol Dial Transplant 1999; 14: 576–580.

Tsukahara H , Shibata R , Ohta N et al. High levels of urinary pentosidine, an advanced glycation end product, in children with acute exacerbation of atopic dermatitis: relationship with oxidative stress. Metabolism 2003; 52: 1601–1605.

Suliman ME , Heimburger O , Barany P et al. Plasma pentosidine is associated with inflammation and malnutrition in end stage renal disease patients starting on dialysis therapy. J Am Soc Nephrol 2003; 14: 1614–1622.

Dawnay A. Renal clearance of glycation adducts: antiglycation defense in uremia and dialysis. Biochem Soc Trans 2003; 31: 1386–1389.

Makita Z , Radoff S , Rayfield EJ et al. Advanced glycation endproducts in patients with diabetic nephropathy. N Eng J Med 1991; 352: 836–842.

10.

Bucala R , Vlassara H . Advanced glycation end products in diabetic renal and vascular disease. Am J Kidney Dis 1995; 26: 875–888.

11.

Kuppusamy UR , Indran M , Tsara A , Wong SW , Tan SY , Mahmood AA . Comparison of oxidative damage in Malaysian end-stage renal disease patients with or without non-insulin dependent diabetes mellitus. Clin Chim Acta 2005; 351: 197–201.

12.

Brownlee M , Cerami A , Vlassara H . Advanced glycosylation end products in tissue and the biochemical basis of diabetic complications. N Eng J Med 1988; 318: 1315–1321.

13.

Stein G , Frank S , Mahiout A et al. Influence of dialysis modalities on serum AGE levels in end-stage renal disease patients. Nephrol Dial Transplant 2001; 16: 999–1008.

14.

Miyata T , Kurokawa K , van Ypersele de Strihou C . Advanced glycation and lipoxidation end products: role of reactive carbonyl compounds generated during carbohydrate and lipid metabolism. J Am Soc Nephrol 2000; 11: 1744–1752.

15.

Tokgoz H , Onaran M , Senocak C , Polat F , Sert S . Temporary vascular access via the external iliac vein as a salvage procedure: a report of two cases. J Vasc Access 2005; 6: 200–202.

16.

Brophy DF , Martin RJ , Gehr TWB , Carr ME . A hypothesis generating study to evaluate platelet activity in diabetics with chronic kidney disease. Thromb J 2005; 3: 3–9.

17.

Obrenovich ME , Monnier VM . Glycation stimulates amyloid formation. Sci Aging Knowledge Environ 2004; 2: pe3-pe3.

18.

Miyata T , Oda O , Inagi R et al. β2-Microglobulin modified with advanced glycation end products is a major component of hemodialysis-associated amyloidosis. J Clin Invest 1993; 92: 1243–1252.

19.

Beisswenger PJ , Moore LL , Brinck-Johnssen T , Churpey TJ . Increased collagen-linked pentosidine levels and advanced glycation end products in early diabetic nephropathy. J Clin Invest 1993; 92: 212–217.

20.

Kislinger T , Fu C , Huber B et al. Nε-(Carboxymethyl) lysine adducts of proteins are ligands for receptor for advanced glycation end products that activate cell signaling pathways and modulated gene expression. J Biol Chem 1999; 274: 31–31 740–749.

21.

Yonekura H , Yamamoto Y , Sakurai S et al. Novel splice variants of the receptor for advanced glycation end-products expressed in human vascular endothelial cells and pericytes, and their putative roles in diabetes-induced vascular injury. Biochem J 2003; 370: 1097–1109.